Real-world data on the abuse potential of medications for the treatment of insomnia: a disproportionality analysis of the FAERS database

This study identified significantly fewer reported cases of real-world abuse, misuse, overdose, and other safety risks for DORAs compared with the unscheduled drug trazodone and scheduled Z-drugs. This suggests that categorization of DORAs as Schedule IV drugs may overstate their abuse potential.